About company

The international pharmaceutical company NoviStem independently performs the full cycle of drug production using a patented technology in the field of bioengineering: from the development and production of an active substance to the production of a finished dosage form and marketing support for products.

Using the best achievements of science in the field of biotechnology, we create fundamentally new opportunities for treating diseases and improving the quality of life of people and animals, without the use of chemicals and dietary supplements.

The development of innovative drugs is carried out in the company's own research centers and laboratories in St. Petersburg and Belgorod. Our first production facility is licensed and produces veterinary drugs in Belgorod, the company's head office is located in Moscow.

Since 1999, our scientists have been developing and implementing methods of cell biotechnology, based on stem cells, in the field of veterinary medicine and classical medicine for the treatment of various types of diseases.

Biological products of our company belong to the class - First-in-class – these are fundamentally new drugs that have not yet been on the market. Important here is the fact that the highly effective indicators of the use of drugs for animals have provided a solid scientific basis for the development of biological products for humans.

We synthesized a protein-peptide complex - a "secret" isolated from the waste products of growing MSCs.

"Secret" launches regenerative processes in the tissues of vital organs by activating the body's own stem cells. As a result, such effects are achieved as normalization of the immune response, rapid regeneration of muscle and cartilage tissues, including the restoration of blood vessels! - after trauma and surgery. The use of NoviStem preparations avoids the formation of scar tissue and limitation of mobility at the site of injury, including paresis and paralysis.

NoviStem reparative preparations are successfully used in veterinary medicine throughout Russia and abroad. It has been clinically proven that NoviStem drugs do not cause embryotoxic, teratogenic and carcinogenic effects.

Join us, let this world be kind and healthy!

Company employees

Elikhanov Adlan

Kharitonov Boris
Commercial Director

Lavrik Alexey
Scientific Director

Shnur Grigory
Chief veterinarian

Production site

The production of veterinary drugs is carried out in accordance with the requirements of good manufacturing practice (GMP), which was confirmed during the inspection by specialists of the central scientific and control institute of Russia VGNKI during the licensing of the site.

The company has implemented and is constantly improving the quality system, which is harmonized with national and international GMP requirements. All production processes, quality control methods, product storage process are validated. The equipment is certified and qualified.

Quality control of manufactured products is currently carried out by outsourcing by an accredited laboratory. The company is currently designing its own quality control laboratory, which will comply with the requirements of ISO:9001, as well as harmonized with the requirements of GLP.

The pharmaceutical quality system annually sets and achieves new goals, which ensures an increase in production efficiency and the quality of developed and manufactured drugs.